Pfaar, O., Kleine-Tebbe, J., Hörmann, K., & Klimek, L. (2011). Allergen-specific immunotherapy: Which outcome measures are useful in monitoring clinical trials? Immunology and allergy clinics of North America, 31(2), . https://doi.org/10.1016/j.iac.2011.02.004
Chicago Style (17th ed.) CitationPfaar, Oliver, Jörg Kleine-Tebbe, Karl Hörmann, and Ludger Klimek. "Allergen-specific Immunotherapy: Which Outcome Measures Are Useful in Monitoring Clinical Trials?" Immunology and Allergy Clinics of North America 31, no. 2 (2011). https://doi.org/10.1016/j.iac.2011.02.004.
MLA (9th ed.) CitationPfaar, Oliver, et al. "Allergen-specific Immunotherapy: Which Outcome Measures Are Useful in Monitoring Clinical Trials?" Immunology and Allergy Clinics of North America, vol. 31, no. 2, 2011, https://doi.org/10.1016/j.iac.2011.02.004.